Skip to main content

Table 2 Surgery and transfusion variables of patients in the three study groups

From: Acute hypervolemic hemodilution combined with controlled hypotension to minimize blood loss during operations of spine fusion: remifentanil versus magnesium sulfate

 

Group I

(N = 18)

Group II

(N = 20)

Group III

(N = 19)

p value

    

Duration of surgery (min)

260 (220–300)

245 (225–320)

255 (235–310)

0.346

    

Estimated blood loss (ml)

1200 (1100–1800)

620 (550–1200)*

650 (600–1250)*

< 0.001

    

Percentage of blood loss (%)

23.8 ± 6.3

12.6 ± 7.3*

13.2 ± 7.2*

< 0.001

    

Number and percentage of patients who received blood, N (%)

13 (72.2%)

6 (30.0%)

7 (36.8%)

0.021

    

Intraoperative RBC transfusion units

3.2 ± 1.2

2.1 ± 1.1*

2.3 ± 1.3*

0.005

    

Baseline Hb (before operation)

11.2 ± 1.3

10.9 ± 1.3

11.1 ± 1.4

0.482

    

Post AHH Hb (after AHH)

9.1 ± 1.3

9.2 ± 1.2

8.9 ± 1.2

0.440

    

Post-transfusion Hb

10.3 ± 1.4

10.2 ± 1.3

10.1±1.3

0.655

    

Postoperative Hb

10.5 ± 1.2

10.4 ± 1.4

10.2±1.4

0.165

    
  1. -Percentage of blood loss (volume of total blood loss/ estimated total blood volume)
  2. -Data are presented as mean ± SD, median (interquartile range), number, and percentage of patients. p < 0.05 is considered significant.
  3. -*Significant in group II or group III in relation to group I.